Vimarsana
Biggest News Aggregation in the World

Page 5 - Array Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Array Biopharma Today - Breaking & Trending Today

Boulder's BioLoomics raises $8.7 million in seed financing – Boulder Daily Camera - Vimarsana News

Boulder's BioLoomics raises $8.7 million in seed financing – Boulder Daily Camera

BioLoomics Inc., a Boulder-based life-sciences startup, has raised $8.7 million in seed financing.

Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief S - Vimarsana News

Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief S

SAN FRANCISCO--(BUSINESS WIRE)--Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, today announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer. Dr. Carter brings a track record of m...

Maintenance Mirvetuximab Soravtansine Plus Bevacizumab Under Exploration in FRα+ Ovarian Cancer - Vimarsana News

Maintenance Mirvetuximab Soravtansine Plus Bevacizumab Under Exploration in FRα+ Ovarian Cancer

The efficacy of maintenance mirvetuximab soravtansine plus bevacizumab is being compared with bevacizumab alone in patients with folate receptor alpha–positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancers that did not progress on second-line triplet therapy in the phase 3 GLORIOSA study.

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma - Vimarsana News

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma

Inaugural Merkin Prize in Biomedical Technology awarded to Dr. Marvin Caruthers for developing technology that efficiently synthesizes DNA - Vimarsana News

Inaugural Merkin Prize in Biomedical Technology awarded to Dr. Marvin Caruthers for developing technology that efficiently synthesizes DNA

/PRNewswire/ -- Dr. Marvin H. Caruthers of the University of Colorado, Boulder, has won the inaugural Richard N. Merkin Prize in Biomedical Technology for...